Study of CBME in the Relief of Painful Diabetic Neuropathy

Summary

The study is designed to investigate the benefit of adding CBME to the existing treatment regime in the management of painful neuropathy. Hypothesis: 1. The addition of CBME to the existing treatment regime will result in a significant improvement in both primary and secondary outcome measures. 2. The side effect profile and tolerability of CBME will be minimal and comparable to placebo.

Timeline

Start

2003-10

Primary completion

—

Completion

2006-03

Drugs

Indications